Sanochemia Pharmazeutika AG out licenses distribution rights for Agileo® (tolperisone) in Turkey
First Quarter Results 2009/2010: Sanochemia Pharmazeutika AG profitable in Q1
Sanochemia permanently discontinues all future payments to AlcaSynn
Successful clinical application of PVP hypericin in the fluorescence diagnosis of bladder cancer
Sanochemia Pharmazeutika AG applies ffor listing in Vienna and relists to Deutsche Börse's General Standard
Displaying results 1 to 5 out of 16
|
| |
